Format

Send to

Choose Destination
Emerg Infect Dis. 2007 Mar;13(3):491-3.

Intermediate vancomycin susceptibility in a community-associated MRSA clone.

Author information

1
Division of Infectious Diseases, University of California, San Francisco General Hospital, 94110, USA. christopher.graber@ucsf.edu

Abstract

We describe a case of treatment failure caused by a strain of USA300 community-associated methicillin-resistant Staphylococcus aureus (MRSA) with intermediate susceptibility to vancomycin and reduced susceptibility to daptomycin. The strain was isolated from the bone of a 56-year-old man with lumbar osteomyelitis after a 6-week treatment course of vancomycin for catheter-associated septic thrombophlebitis.

PMID:
17552110
PMCID:
PMC2725904
DOI:
10.3201/eid1303.060960
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for CDC-NCEZID Icon for PubMed Central
Loading ...
Support Center